Biodesix, Inc. reaffirmed revenue guidance for the year 2023. For the year, the company expects total revenue to be between $52 million to $55 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.575 USD | +0.32% | +5.02% | -14.67% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.67% | 178M | |
-22.04% | 8.54B | |
+68.65% | 4.32B | |
-0.82% | 2.53B | |
-39.22% | 2.48B | |
-9.30% | 1.9B | |
-18.90% | 1.59B | |
-40.70% | 1.23B | |
+13.38% | 1.13B | |
+16.15% | 994M |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Reaffirms Revenue Guidance for the Year 2023